Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Understanding what not to do when budgeting is crucial for financial success. Learn the common mistakes to steer clear of.
26,044 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
SpaceX plans a June IPO that would place a second Musk-led company in the public eye, raising questions about how muc...
The AFL-CIO argues the Senate version of the CLARITY Act could channel digital assets into retirement accounts with w...
Gas costs are lifting travel bills for Memorial Day weekend, with households facing higher pump prices and investors ...
As markets swing in May 2026, PJUL caps your gains at a defined ceiling while protecting against early losses, a path...
Investors and policymakers are weighing a potential framework to end decades-long Iran tensions and reopen the Strait...
A shrinking market breadth exposes investors to a narrow rally as earnings revisions pile up around AI-related names....
Oil prices stayed contained as Beijing taps strategic stockpiles, a trend analysts say explains why crude hasn’t surg...
This article offers a clear, original look at Champion Homes (SKY) 2026 earnings outlook. Learn the key drivers, what...
The quarter is over and the magnificent seven done reporting. Here are three buys that stand out for ambitious invest...
As Movado prepares for its Q1 2027 earnings, investors want clarity on demand, margins, and licensing deals. This gui...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...